ZA201403574B - Methods for treating gout in patient subpopulations - Google Patents

Methods for treating gout in patient subpopulations

Info

Publication number
ZA201403574B
ZA201403574B ZA2014/03574A ZA201403574A ZA201403574B ZA 201403574 B ZA201403574 B ZA 201403574B ZA 2014/03574 A ZA2014/03574 A ZA 2014/03574A ZA 201403574 A ZA201403574 A ZA 201403574A ZA 201403574 B ZA201403574 B ZA 201403574B
Authority
ZA
South Africa
Prior art keywords
methods
treating gout
patient subpopulations
subpopulations
patient
Prior art date
Application number
ZA2014/03574A
Other languages
English (en)
Inventor
A Mcwherter Charles
K Roberts Brian
chandra saha Gopal
Edward Lavan Brian
Original Assignee
Cymabay Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cymabay Therapeutics Inc filed Critical Cymabay Therapeutics Inc
Publication of ZA201403574B publication Critical patent/ZA201403574B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2014/03574A 2011-11-04 2014-05-16 Methods for treating gout in patient subpopulations ZA201403574B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/059425 WO2013066352A1 (en) 2011-11-04 2011-11-04 Methods for treating gout in patient subpopulations

Publications (1)

Publication Number Publication Date
ZA201403574B true ZA201403574B (en) 2015-11-25

Family

ID=48192536

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/03574A ZA201403574B (en) 2011-11-04 2014-05-16 Methods for treating gout in patient subpopulations

Country Status (14)

Country Link
EP (1) EP2775835A4 (https=)
JP (1) JP6047172B2 (https=)
KR (1) KR101848122B1 (https=)
CN (1) CN104066323A (https=)
AU (1) AU2011380509B2 (https=)
BR (1) BR112014010693A2 (https=)
CA (1) CA2859689C (https=)
CL (1) CL2014001156A1 (https=)
IL (1) IL232385A (https=)
MX (1) MX354846B (https=)
NZ (1) NZ624714A (https=)
SG (1) SG11201402027PA (https=)
WO (1) WO2013066352A1 (https=)
ZA (1) ZA201403574B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013155478A1 (en) * 2012-04-13 2013-10-17 Metabolex, Inc. Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent
CN105851522A (zh) * 2014-07-25 2016-08-17 许伟琦 一种防止尿路结石的饲料
CN105920022A (zh) * 2016-05-12 2016-09-07 成都易创思生物科技有限公司 一种抗痛风药物复方制剂
KR102666724B1 (ko) * 2017-10-26 2024-05-20 오츠카 세이야쿠 가부시키가이샤 이노시톨인산 함유 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250191A (en) * 1978-11-30 1981-02-10 Edwards K David Preventing renal failure
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
ME01294B (me) * 2007-11-27 2013-06-20 Ardea Biosciences Inc Nova jedinjenja i kompozicije i metode upotrebe

Also Published As

Publication number Publication date
CA2859689C (en) 2018-05-22
AU2011380509A1 (en) 2014-05-29
MX2014005399A (es) 2015-04-08
SG11201402027PA (en) 2014-09-26
CN104066323A (zh) 2014-09-24
NZ624714A (en) 2016-01-29
AU2011380509B2 (en) 2016-05-19
MX354846B (es) 2018-03-22
WO2013066352A1 (en) 2013-05-10
EP2775835A1 (en) 2014-09-17
KR20140123927A (ko) 2014-10-23
JP2014532759A (ja) 2014-12-08
JP6047172B2 (ja) 2016-12-21
IL232385A (en) 2017-10-31
KR101848122B1 (ko) 2018-04-11
IL232385A0 (en) 2014-06-30
CA2859689A1 (en) 2013-05-10
EP2775835A4 (en) 2015-07-29
BR112014010693A2 (pt) 2020-11-10
CL2014001156A1 (es) 2015-01-16

Similar Documents

Publication Publication Date Title
HRP20180882T1 (hr) Sredstva za i postupci liječenja dlbcl
HUE045988T2 (hu) Csúsztatható berendezés hõterápiás kezeléshez
EP2531625A4 (en) PROCESS FOR PROCESSING FRACTURE MATERIALS
ZA201208219B (en) Method for treating wasterwater
PL2735250T3 (pl) Urządzenie typu przesuwnego dla leczenia termo terapeutycznego
IL220594A0 (en) Treatment method
SG11201401981TA (en) Methods for treating gout flares
ZA201403574B (en) Methods for treating gout in patient subpopulations
GB201105523D0 (en) Treatment method
ZA201308117B (en) Avian-based treatment
IL228744A0 (en) A method for treating diseases related to interferon alpha
GB201121950D0 (en) Treatment process
EP2813798A4 (en) METHOD OF EXPLOSION TREATMENT
SG11201402309YA (en) Process for medical components and uses thereof
GB201102283D0 (en) Treatment
EP2768536A4 (en) METHOD OF TREATING TYPE I AND TYPE II DIABETES
GB201109796D0 (en) Treatment device
SG11201403180YA (en) Improvements in machining apparatus
GB201102288D0 (en) Treatment
GB201111247D0 (en) Treatment
GB201102274D0 (en) Treatment
GB201102273D0 (en) Treatment
GB201102272D0 (en) Treatment
GB201102271D0 (en) Treatment
GB201102270D0 (en) Treatment